VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BYAH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
BYAHPark Ha Biological Technology Co., Ltd. Ordinary Shares
$1.15$42M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

BYAH logoPark Ha Biological Technology Co., Ltd. Ordinary Shares(BYAH)Earnings, Financials & Key Ratios

BYAH•NASDAQ
$1.15
62.8× P/E·Price updated Jun 27, 2026
SectorConsumer CyclicalIndustryPersonal ServicesSub-IndustryBeauty Services and Personal Care Brands
AboutThe company is an investment holding company that develops skincare products under the “Park Ha” brand in the People’s Republic of China, through its subsidiaries operating in direct product sales and franchise services.Show more
  • Revenue$2M-3.1%
  • EBITDA$816K-32.0%
  • Net Income$479K-43.8%
  • EPS (Diluted)0.02-43.7%
  • Gross Margin91.8%+5.1%
  • EBITDA Margin34.28%-29.8%
  • Operating Margin33.32%-30.6%
  • Net Margin20.09%-42.0%
  • ROE38%-74.1%

BYAH Price & Volume

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) stock price & volume — 10-year historical chart

Loading chart...

Elite Gross Margins Mask Revenue Contraction Risks

Investment Thesis • Updated N/A

VerdictNeutral
Growth:Contracting
Profitability:Strong
Financial:Healthy
Cash Flow:Mixed
Primary Risk:Geopolitical and Regulatory Exposure

Key Thesis Takeaways

  • Park Ha Biological Technology exhibits a bifurcated profile characterized by exceptional 91.80% gross margins alongside a concerning 3.14% year-over-year revenue decline, suggesting that its franchise-based distribution model is struggling with market saturation.
  • While the company maintains a pristine balance sheet with a negligible 0.05% debt-to-equity ratio, the lack of transparent cash flow data obscures the true quality of its 20.09% net margin.
  • Investors should monitor the sustainability of these premium margins against the backdrop of significant geopolitical and regulatory exposure inherent in its Chinese operational structure.

Verdict Logic

while the company reports a strong 20.09% net margin, the high 51.11x EV/EBITDA valuation combined with opaque cash flow reporting warrants a cautious wait-and-see approach.

BYAH Growth Metrics

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years36.77%
TTM-

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-

Return on Capital

10 Years131.34%
5 Years131.34%
3 Years131.34%
Last Year61.51%

Latest BYAH News

Recent stock market news and headlines for Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH)

GlobeNewsWire·6 days ago
Park Ha Biological Technology Co., Ltd. announces strategic partnership with Cloud Factory Technology Holdings Limited (02512.HK) to build an AI-driven ecosystem for the beauty industry.

Wuxi, China, June 23, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (“Park Ha Biological” or the “Company”) announced that the Company has established a comprehensive strategic partnership with Cloud Factory Technology Holdings Limited (02512.HK), a company listed on The Stock Exchange of Hong Kong (“Cloud Factory”).

GlobeNewsWire·Jun 15, 2026
Park Ha Biological Technology Co., Ltd. Announces Closing of $2.0 Million Registered Direct Offering

Wuxi, China, June 15, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd., (NASDAQ: BYAH) an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Company”), today announced the closing of its previously announced registered direct offering with several investors for the sale and purchase of an aggregate of up to 1,133,332 of the Company's Class A ordinary shares, par value $0.001 each (the “Class A Ordinary Shares”), and pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 200,000 Class A Ordinary Shares, at a combined purchase price of $1.50 per Class A Ordinary Share and Pre-Funded Warrant.

Peers Comparison

Key metrics vs top competitors for Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
BYAH logoBYAHPark Ha Biological Technology Co., Ltd. Ordinary SharesCurrent
$1.15$42.2M62.84-3.14%20.09%38%—
CLPS logoCLPSCLPS Incorporation
$0.85$25.33M-3.2815.17%-3.05%-15.02%—
CNET logoCNETZW Data Action Technologies Inc.
$0.92$3.01M-1.37-70.11%-33.27%-28.25%—
RETO logoRETOReTo Eco-Solutions, Inc.
$2.60$4.91M-1.0184.3%-397.95%-80.63%—
AGRI logoAGRIAgriFORCE Growing Systems Ltd.
$0.77$311.84K-0.02-100%-3666.64%-91.85%—
BTBT logoBTBTBit Digital, Inc.
$1.99$648.02M-6.42-30.65%-146.01%-0.11%—

Compare BYAH vs Peers

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs CLPS

Most directly comparable listed peer for BYAH.

Scale Benchmark

vs NVAX

Larger-name benchmark to compare BYAH against a more recognizable public peer.

Peer Set

Compare Top 5

vs CLPS, CNET, RETO, AGRI

Get notified when BYAH posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

BYAH Frequently Asked Questions

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Park Ha Biological Technology Co., Ltd. Ordinary Shares's revenue?

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) reported $2.4M in revenue for fiscal year 2024. This represents a 156% increase from $0.9M in 2021.

How fast is Park Ha Biological Technology Co., Ltd. Ordinary Shares growing?

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) saw revenue decline by 3.1% over the past year.

Is BYAH profitable?

Yes, Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) is profitable, generating $0.5M in net income for fiscal year 2024 (20.1% net margin).

Dividend & Returns
What is BYAH's return on equity?

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) has a return on equity (ROE) of 38.0%. This is excellent, indicating efficient use of shareholder capital.

What is Park Ha Biological Technology Co., Ltd. Ordinary Shares's free cash flow?

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) generated $0.9M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in BYAH back in 2021?

Total return calculator · dividends reinvested · 5+ years of data

See returns →